Incidence and outcomes of new and persistent use of proton pump inhibitors following percutaneous coronary intervention: a retrospective population-based study

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Leon Arnar Heitmann

Reykjavik (Iceland)

4 More presentations in this session

Presentation thumbnail

Discussant - Acute coronary syndromes and pharmacotherapy

Presentation thumbnail

Mortality patterns during ten years of follow-up after primary PCI for STEMI

Doctor N. Herity (Belfast, GB)

Abstract Slides Video

Presentation thumbnail

The role of left ventricular ejection fraction grade in differentiating outcomes of Non-ST-segment elevation myocardial infarction and ST-segment elevation myocardial infarction

Professor Y. Kim (Chuncheon, KR)

Abstract Slides Video

Presentation thumbnail

The implication of early bleeding on subsequent clinical outcomes in patients with coronary artery disease and atrial fibrillation: a subgroup analysis of the EPIC-CAD trial

Doctor S. An (Seoul, KR)

Access the full session

Session thumbnail

New perspectives in cardiology (2) - Acute coronary syndromes and pharmacotherapy

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Association between reduced risk of gastrointestinal bleeding related to proton pump inhibitor use and subsequent all-cause death in patients with percutaneous coronary intervention

Congress Presentation

Interplay among proton pump inhibitors, platelet reactivity and CYP2C19 genotyping in clopidogrel-treated patients after drug-eluting stent implantation

Congress Presentation

Upper gastrointestinal bleeding events after myocardial infarction: long-term insights from nationwide Swedish registries

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources